Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyeon Park

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2021
Post-Transplant Cardiovascular DiseaseKelly A Birdwell, Meyeon Park
Seminars in Oncology|December 6, 2006
Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancerMeyeon Park, Rebecca Davidson, Kevin Fox
Clinical Transplantation|December 12, 2022
Post-transplant ejection fraction and renal failure in cardiac transplant recipients: An analysis of the OPTN databaseMason Lai, Mandar A Aras, Meyeon Park
Hepatology (Baltimore, Md.)|April 27, 2018
"Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With CirrhosisGiuseppe Cullaro, Meyeon Park, Jennifer C Lai
Advances in Kidney Disease and Health|April 23, 2023
Pharmacologic Management of Autosomal Dominant Polycystic Kidney DiseaseWilliam Ackley, Neera K Dahl, Meyeon Park
BMC Nephrology|May 1, 2023
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative ApproachJuliana Smith, Orlando O Harris, Deborah Adey, et al.
Clinical Nephrology|August 15, 2018
Subclinical metabolic and cardiovascular abnormalities in autosomal dominant polycystic kidney disease
Radha Chirumamilla, Diana Mina, Salpi Siyahian, et al.
La Revue De Medecine Interne|June 18, 2026
Autosomal dominant polycystic kidney disease: Current perspectives in 2026Maude Pichette, Meyeon Park, Emilie Cornec-Le Gall
BMJ Case Reports|May 26, 2019
Primary aldosteronism associated with a germline variant in <i>CACNA1H</i>Kendra Wulczyn, Edward Perez-Reyes, Robert L Nussbaum, et al.
Atherosclerosis|June 12, 2017
Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul StudyMeyeon Park, Daniela Maristany, Debbie Huang, et al.
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Clinical Journal of the American Society of Nephrology : CJASN|September 24, 2021
Post-Transplant Cardiovascular DiseaseKelly A Birdwell, Meyeon Park
Seminars in Oncology|December 6, 2006
Preservation of fertility and the impact of subsequent pregnancy in patients with premenopausal breast cancerMeyeon Park, Rebecca Davidson, Kevin Fox
Clinical Transplantation|December 12, 2022
Post-transplant ejection fraction and renal failure in cardiac transplant recipients: An analysis of the OPTN databaseMason Lai, Mandar A Aras, Meyeon Park
Hepatology (Baltimore, Md.)|April 27, 2018
"Normal" Creatinine Levels Predict Persistent Kidney Injury and Waitlist Mortality in Outpatients With CirrhosisGiuseppe Cullaro, Meyeon Park, Jennifer C Lai
Advances in Kidney Disease and Health|April 23, 2023
Pharmacologic Management of Autosomal Dominant Polycystic Kidney DiseaseWilliam Ackley, Neera K Dahl, Meyeon Park
BMC Nephrology|May 1, 2023
Barriers and facilitators to the transplant process among patients living with polycystic kidney disease: a qualitative ApproachJuliana Smith, Orlando O Harris, Deborah Adey, et al.
Clinical Nephrology|August 15, 2018
Subclinical metabolic and cardiovascular abnormalities in autosomal dominant polycystic kidney disease
Radha Chirumamilla, Diana Mina, Salpi Siyahian, et al.
La Revue De Medecine Interne|June 18, 2026
Autosomal dominant polycystic kidney disease: Current perspectives in 2026Maude Pichette, Meyeon Park, Emilie Cornec-Le Gall
BMJ Case Reports|May 26, 2019
Primary aldosteronism associated with a germline variant in <i>CACNA1H</i>Kendra Wulczyn, Edward Perez-Reyes, Robert L Nussbaum, et al.
Atherosclerosis|June 12, 2017
Associations of tumor necrosis factor alpha receptor type 1 with kidney function decline, cardiovascular events, and mortality risk in persons with coronary artery disease: Data from the Heart and Soul StudyMeyeon Park, Daniela Maristany, Debbie Huang, et al.
Pageof 5